Bacterial infection-related morbidity and mortality in cirrhosis

American Journal of Gastroenterology

Volumn 102, Issue 7, 2007, Pages 1510-1517

  Christou, Leonidas ^a   Pappas, Georgios ^b   Falagas, Matthew E ^c,d  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Institute of Continuing Medical Education of Ioannina   (Greece)

^c ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN M; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AEROMONAS; BACTEREMIA; BACTERIAL INFECTION; CAMPYLOBACTER; CLOSTRIDIUM; COLITIS; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ENDOCARDITIS; ESCHERICHIA COLI; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFECTIOUS COMPLICATION; KLEBSIELLA; LIVER ABSCESS; LIVER CIRRHOSIS; MEDICAL LITERATURE; MEDLINE; MENINGITIS; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PASTEURELLA MULTOCIDA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETICULOENDOTHELIAL SYSTEM; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS BOVIS; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION; VIBRIO CHOLERAE; VIBRIO VULNIFICUS;

BACTERIAL INFECTIONS; HUMANS; LIVER CIRRHOSIS; MORBIDITY; RISK FACTORS; SURVIVAL RATE; WORLD HEALTH;

EID: 34250828060     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01286.x     Document Type: Review

References (87)

1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002 2 : 395 403.
2. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999 340 : 745 50.
3. Bran OS. Infectious complications of cirrhosis. Curr Gastroenterol Rep 2001 3 : 285 92.
4. Crossley IR, Williams R. Spontaneous bacterial peritonitis. Gut 1985 26 : 325 31.
5. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001 120 : 726 48.
6. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document. International Ascites Club. J Hepatol 2000 32 : 142 53.
7. Riley TR, Smith JP. Preventive care in chronic liver disease. J Gen Intern Med 1999 14 : 699 704.
8. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005 41 : 422 33.
9. Fiuza C, Salcedo M, Clemente G, et al. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000 182 : 526 33.
10. Fiuza C, Salcedo M, Clemente G, et al. Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease. Clin Diagn Lab Immunol 2002 9 : 433 9.
11. Trevisani F, Castelli E, Foschi FG, et al. Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome. Gut 2002 50 : 707 12.
12. Garfia C, Garcia-Ruiz I, Solis-Herruzo JA. Deficient phospholipase C activity in blood polimorphonuclear neutrophils from patients with liver cirrhosis. J Hepatol 2004 40 : 749 56.
13. Rimola A, Soto R, Bory F, et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984 4 : 53 8.
14. Akalin HE, Laleli Y, Telatar H. Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis. Q J Med 1985 56 : 431 7.
15. Homann C, Varming K, Hogasen K, et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 1997 40 : 544 9.
16. Ono Y, Watanabe T, Matsumoto K, et al. Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood. J Infect Chemother 2004 10 : 200 7.
17. Olmos JM, Garcia JD, Jimenez A, et al. Impaired monocyte function in primary biliary cirrhosis. Allergol Immunopathol (Madr) 1988 16 : 353 8.
18. Gomez F, Ruiz P, Schreiber AD. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 1994 331 : 1122 8.
19. Wang SS, Lee FY, Chan CC, et al. Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection. Clin Sci (Lond) 2000 98 : 419 25.
20. Byl B, Roucloux I, Crusiaux A, et al. Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 1993 104 : 1492 7.
21. Espat NJ, Auffenberg T, Abouhamze A, et al. A role for tumor necrosis factor-alpha in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann Surg 1996 223 : 428 33.
22. Wong F, Bernardi M, Balk R, et al. Sepsis in cirrhosis: Report on the 7th meeting of the International Ascites Club. Gut 2005 54 : 718 25.
23. Wyke RJ, Rajkovic IA, Williams R. Impaired opsonization by serum from patients with chronic liver disease. Clin Exp Immunol 1983 51 : 91 8.
24. De Fernandez MA, Clark A, Triger DR. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases. Clin Exp Immunol 1987 67 : 655 61.
25. Yousif-Kadaru AG, Rajkovic IA, Wyke RJ, et al. Defects in serum attractant activity in different types of chronic liver disease. Gut 1984 25 : 79 84.
26. Onishi S, Saibara T, Maeda T, et al. Serum inhibition of complement derived leukocyte chemotaxis and levels of immunoglobulin A subclass in alcoholic liver disease. Gastroenterol Jpn 1989 24 : 284 9.
27. Fierer J, Finley F. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest 1979 63 : 912 21.
28. Preheim LC, Gentry MJ, Snitily MU. Pulmonary recruitment, adherence, and chemotaxis of neutrophils in a rat model of cirrhosis and pneumococcal pneumonia. J Infect Dis 1991 164 : 1203 6.
29. Akritidis N, Pappas G. Ascites caused by brucellosis: A report of two cases. Scand J Gastroenterol 2001 36 : 110 2.
30. Wyke RJ. Bacterial infections complicating liver disease. Baillieres Clin Gastroenterol 1989 3 : 187 210.
31. Butler P, Hamilton-Miller JM, McIntyre N, et al. Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups. Gut 1995 36 : 931 4.
32. Linderoth G, Jepsen P, Schonheyder HC, et al. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study. Alcohol Clin Exp Res 2006 30 : 636 41.
33. Monte Secades R, Casariego Vales E, Mateos Colino A, et al. Clinical profile and prognosis of bacteremia in patients with cirrhosis based on the Child-Pugh classification. Rev Clin Esp 1999 199 : 716 21. In Spanish.
34. Amdal T, Skinhoj P, Friis H. Bacteremia in patients suffering from cirrhosis. Infection 1986 14 : 68 70.
35. Terra C, Guevara M, Torre A, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: Value of MELD score. Gastroenterology 2005 129 : 1944 53.
36. Thulstrup AM, Sorensen HT, Schonheyder HC, et al. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 2000 31 : 1357 61.
37. Henrion J, Schapira M, Derue G, et al. Prevention of bacterial infection using selective intestinal decontamination in patients with cirrhosis admitted to intensive care. Controlled study in 120 patients. Acta Gastroenterol Belg 1992 55 : 333 40. In French.
38. Jarcuska P, Veseliny E, Orolin M, et al. Infectious complications in patients with liver cirrhosis. Klin Mikrobiol Infekc Lek 2004 10 : 176 80. In Slovak.
39. Frenandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002 35 : 140 8.
40. Hara K, Kohno S, Koga H, et al. Infections in patients with liver cirrhosis and hepatocellular carcinoma. Intern Med 1995 34 : 491 5.
41. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993 18 : 353 8.
42. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: A multicentre prospective study. Dig Liver Dis 2001 33 : 41 8.
43. Rosa H, Silverio AO, Perini RF, et al. Bacterial infection in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol 2000 95 : 1290 3.
44. Kuo CH, Changchien CS, Yang CY, et al. Bacteremia in patients with cirrhosis of the liver. Liver 1991 11 : 334 9.
45. Strauss E, da Costa MF. The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology 1998 45 : 900 4.
46. Gershwin ME, Selmi C, Worman HJ, et al. Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients. Hepatology 2005 42 : 1194 202.
47. Bogdanos DP, Baum H, Butler P, et al. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis 2003 35 : 801 5.
48. O'Donohue J, Workman MR, Rolando N, et al. Urinary tract infections in primary biliary cirrhosis and other chronic liver diseases. Eur J Clin Microbiol Infect Dis 1997 16 : 743 6.
49. Molle I, Thulstrup AM, Svendsen N, et al. Risk and case fatality rate of meningitis in patients with liver cirrhosis. Scand J Infect Dis 2000 32 : 407 10.
50. Pauwels A, Pines E, Abboura M, et al. Bacterial meningitis in cirrhosis: Review of 16 cases. J Hepatol 1997 27 : 830 4.
51. McCashland TM, Sorrell MF, Zetterman RK. Bacterial endocarditis in patients with chronic liver disease. Am J Gastroenterol 1994 89 : 924 7.
52. Satoh T, Sasatomi E, Wu L, et al. Phlegmonous colitis: A specific and severe complication of chronic hepatic disease. Virchows Arch 2000 437 : 656 61.
53. Molle I, Thulstrup AM, Vilstrup H, et al. Increased risk and case fatality rate of pyogenic liver abscess in patients with liver cirrhosis: A nationwide study in Denmark. Gut 2001 48 : 260 3.
54. Yoneyama K, Miyagishi K, Kiuchi Y, et al. Risk factors for infections in cirrhotic patients with and without hepatocellular carcinoma. J Gastroenterol 2002 37 : 1028 34.
55. Yoshida H, Hamada T, Inuzuka S, et al. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am J Gastroenterol 1993 88 : 2067 71.
56. Soares-Weiser K, Brezis M, Tur Kaspa R, et al. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002 CD002907.
57. Thalheimer U, Triantos CK, Samonakis DN, et al. Infection, coagulation, and variceal bleeding in cirrhosis. Gut 2005 54 : 556 63.
58. Llach J, Elizalde JI, Bordas JM, et al. Prospective assessment of the risk of bacteremia in cirrhotic patients undergoing lower intestinal endoscopy. Gastrointest Endosc 1999 49 : 214 7.
59. Pohl J, Ring A, Stremmel W, et al. The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2006 18 : 69 74.
60. Bjornsson ES, Kilander AF, Olsson RG. Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis-a study of bile cultures from ERCP. Hepatogastroenterology 2000 47 : 1504 8.
61. Kulaksiz H, Rudolph G, Kloeters-Plachky P, et al. Biliary candida infections in primary sclerosing cholangitis. J Hepatol 2006 45 : 711 6.
62. Ponsioen CY, Defoer J, Ten Kate FJ, et al. A survey of infectious agents as risk factors for primary sclerosing cholangitis: Are Chlamydia species involved? Eur J Gastroenterol Hepatol 2002 14 : 641 8.
63. Ko WC, Chuang YC. Aeromonas bacteremia: Review of 59 episodes. Clin Infect Dis 1995 20 : 1298 304.
64. Pigrau C, Bartolome R, Almirante B, et al. Bacteremia due to Campylobacter species: Clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 1997 25 : 1414 20.
65. Chen YM, Lee HC, Chang CM, et al. Clostridium bacteremia: Emphasis on the poor prognosis in cirrhotic patients. J Microbiol Immunol Infect 2001 34 : 113 8.
66. Cheng NC, Tai HC, Tang YB, et al. Necrotising fasciitis: Clinical features in patients with liver cirrhosis. Br J Plast Surg 2005 58 : 702 7.
67. Ortiz J, Vila MC, Soriano G, et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 1999 29 : 1064 9.
68. Wang LS, Lee FY, Cheng DL, et al. Klebsiella pneumoniae bacteremia: Analysis of 100 episodes. J Formos Med Assoc 1990 89 : 756 63.
69. Lu Ch, Chang WN, Wu HS. Klebsiella pneumoniae meningitis: Analysis on clinical features of thirty-two adult patients. Zhonghua Yi Xue Za Zhi (Taipei) 1997 60 : 296 302.
70. Thulstrup AM, Molle I, Svendsen N, et al. Incidence and prognosis of tuberculosis in patients with cirrhosis of the liver. A Danish nationwide population based study. Epidemiol Infect 2000 124 : 221 5.
71. Arevalo M, Solera J, Cebrian D, et al. Risk factors associated with drug-resistant Mycobacterium tuberculosis in Castilla-la-Mancha (Spain). Eur Respir J 1996 9 : 274 8.
72. Raffi F, Barrier J, Baron D, et al. Pasteurella multocida bacteremia: Report of thirteen cases over twelve years and review of the literature. Scand J Infect Dis 1987 19 : 385 93.
73. Hsu RB, Chen RJ, Chu SH. Nontyphoid Salmonella bacteremia in patients with liver cirrhosis. Am J Med Sci 2005 329 : 234 7.
74. Chapoutot C, Pageaux GP, Perrigault PF, et al. Staphylococcus aureus nasal carriage in 104 cirrhotic and control patients. A prospective study. J Hepatol 1999 30 : 249 53.
75. Chang FY, Singh N, Gayowski T, et al. Staphylococcus aureus nasal colonization in patients with cirrhosis: Prospective assessment of association with infection. Infect Control Hosp Epidemiol 1998 19 : 328 32.
76. Campillo B, Richardet JP, Kheo T, et al. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: Impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 2002 35 : 1 10.
77. Gonzlez-Quintela A, Martinez-Rey C, Castroagudin JF, et al. Prevalence of liver disease in patients with Streptococcus bovis bacteraemia. J Infect 2001 42 : 116 9.
78. Jackson LA, Hilsdon R, Farley MM, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995 123 : 415 20.
79. Bouza E, Pintado V, Rivera S, et al. Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect 2005 11 : 919 24.
80. Lee CK, Liu JW, Leu HS, et al. Streptococcus pneumoniae bacteremia in southern Taiwan. J Microbiol Immunol Infect 2002 35 : 17 22.
81. Pirovino M, Lydick E, Grob PJ, et al. Pneumococcal vaccination: The response of patients with alcoholic liver cirrhosis. Hepatology 1984 4 : 946 9.
82. Preheim LC, Mellencamp MA, Snitily NU, et al. Effect of cirrhosis on the production and efficacy of pneumococcal capsular antibody in a rat model. Am Rev Respir Dis 1992 146 : 1054 8.
83. Lin CJ, Chiu CT, Lin DY, et al. Non-O1 Vibrio cholerae bacteremia in patients with cirrhosis: 5-yr experience from a single medical center. Am J Gastroenterol 1996 91 : 336 40.
84. Chiang SR, Chuang YC. Vibrio vulnificus infection: Clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect 2003 36 : 81 8.
85. Vadillo M, Corbella X, Pac V, et al. Multiple liver abscesses due to Yersinia enterocolitica discloses primary hemochromatosis: Three case reports and review. Clin Infect Dis 1994 18 : 938 41.
86. Andrade RJ, Lucena MI, Fernandez MC, et al. Hepatotoxicity in patients with cirrhosis, an often unrecognized problem: Lessons from a fatal case related to amoxicillin/clavulanic acid. Dig Dis Sci 2001 46 : 1416 9.
87. Campillo B, Dupeyron C, Richardet JP, et al. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: Effect of long-term administration of norfloxacin. Clin Infect Dis 1998 26 : 1066 70.